Raymond James & Associates’s Humacyte HUMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$235K	Buy	+43,278	New	+$235K	﹤0.01%	3517
2023 Q2	–	Sell	-19,411	Closed	-$60K	–	3823
2023 Q1	$60K	Buy	+19,411	New	+$60K	﹤0.01%	3671